CoreCap Advisors LLC Sells 2,153 Shares of Intuitive Surgical, Inc. $ISRG

CoreCap Advisors LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 68.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,009 shares of the medical equipment provider’s stock after selling 2,153 shares during the period. CoreCap Advisors LLC’s holdings in Intuitive Surgical were worth $571,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the company. Holos Integrated Wealth LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at $25,000. Kilter Group LLC bought a new stake in Intuitive Surgical during the second quarter valued at $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in Intuitive Surgical during the 3rd quarter worth about $27,000. Olistico Wealth LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth about $28,000. Finally, Caitlin John LLC bought a new position in shares of Intuitive Surgical in the 3rd quarter worth about $30,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

ISRG stock opened at $452.77 on Tuesday. The stock’s 50 day simple moving average is $492.86 and its 200 day simple moving average is $513.66. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The company has a market cap of $160.79 billion, a P/E ratio of 57.39, a price-to-earnings-growth ratio of 3.49 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.21 earnings per share. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on ISRG shares. Raymond James Financial boosted their price objective on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Truist Financial raised their target price on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. Robert W. Baird dropped their price target on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. UBS Group cut their price target on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a report on Tuesday, March 17th. Finally, Argus reduced their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $614.95.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the sale, the executive vice president owned 409 shares in the company, valued at approximately $202,438.64. The trade was a 50.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of the company’s stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the transaction, the director owned 3,694 shares in the company, valued at approximately $1,958,189.40. The trade was a 86.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 32,943 shares of company stock worth $17,279,568 over the last quarter. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.